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In February 2011, a rare case of congenital Plasmodium vivax malaria was diagnosed in a temperate region of
Central China. An infant developed intermittent fever 20 days after delivery. Since this occurred during the non-
transmission winter season in a low malaria endemic region and the infant’s mother did not have a clear malaria
history or showed malaria symptoms at the time of the delivery, malaria infection was not suspected at the
beginning. Later, on suspicion of potential malignant haematological illness due to persistence of the fever, bone
marrow smear was examined, which revealed infection by P. vivax parasite. This rare case of congenital vivax
malaria underlines that malaria diagnosis might need to be included in the healthcare of neonates born in vivax-
endemic areas.Background
Congenital malaria is associated with significant neonatal
mortality [1]. Some studies performed in hyperendemic
areas suggested that congenital malaria is uncommon
[2-5], whereas others have shown that it occurs signifi-
cantly more frequently than was previously considered
[6-9]. In comparison, reports of congenital malaria in
hypoendemic areas have been even rarer. Since the
symptoms of congenital malaria are usually atypical, and
difficult to diagnose, it often results in delayed anti-mal-
arial treatment [10]. Therefore, it was suggested that
malaria diagnosis should be included as part of routine
healthcare for all neonates in malaria hyperendemic
areas [9,11].
Compared to Plasmodium falciparum, Plasmodium
vivax has a much wider distribution outside Africa and
it extends far into the temperate zones. Recently, P.
vivax has been shown to be not as benign as it was pre-
viously thought and is associated with complications,
such as severe anaemia, respiratory distress, malnutri-
tion, and even coma [12]. In addition, P. vivax has been
found to be a major cause of morbidity in young chil-
dren [13]. Besides, P. vivax can cause relapses due to the
presence of long-lived latent forms in the liver, known as* Correspondence: xiahui912@hotmail.com; luc2@psu.edu
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hypnozoites, patients may suffer relapses. In the tropics,
P. vivax strains are characterized by early primary infec-
tion followed by frequent relapses. In temperate areas,
however, primary infection tends to occur later with long
intervals and fewer and later relapses as adaptation to
climatic conditions to avoid the lengthy winter when the
mosquito vector is unavailable [14,15]. Relapse not only
renders P. vivax resistant to eradication, but also makes
diagnosis difficult during the winter season when natural
malaria transmission is absent. Here is a report of a rare
case of congenital vivax malaria, which occurred in a
hypoendemic, temperate area during the cold winter
season.
Case presentation
A 20-year old primigravida delivered a boy on February
7, 2011, in the Department Obstetrics of Bengbu First
People's Hospital, Anhui Province, China. The newborn
had a gestational age of 37 weeks, weighed 1.95 kg, and
the Apgar score was 10 at 1 minute. Because of low
body weight compared with normal birth weight of
3.6 ± 0.4 kg at the same gestational age, he was trans-
ferred to the neonatal intensive care unit immediately
after delivery. He was discharged from the hospital at
the age of 20 days. At home, he had fever for five hours
on the same day, and was returned and admitted to the
hospital for treatment. Physical and laboratory examina-
tions were performed immediately.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Results of blood routine tests of the infant
Day* WBC(×109/L) Hb(g/L) RBC(×1012/L) Hematocrit(%) PLT(×109/L)
2 34.4 147 4.32 54.0 57
4 12.7 142 4.55 47.3 46
8 8.6 87 2.72 17.1 36
12 7.3 78 2.45 24.5 141
19 8.0 98 3.23 32.5 138
*Day since the infant was readmitted to the hospital. Anti-malarial treatment
started on day 12
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body temperature of 38.5°C and body weight of 1.97 Kg.
His liver was palpable with a span of 2 cm both below
the right costal margin and below the sternum, while the
spleen was not palpable. Coarse breath sounds without
rales were heard over both lung fields. There was no evi-
dence of jaundice. Laboratory blood test results showed
that the infant had a white blood cell (WBC) count of
34.4 × 109/L with 39.5% polymorphonuclear leukocytes
and 52.2% lymphocytes, and a platelet (PLT) count of
57 × 109/L. His haemoglobin (Hb) level was 147 g/L. He
had a total bilirubin level of 295.6 μmol/L (≤205 μmol/L
as normal) and direct bilirubin level of 16.5 μmol/L
(≤34 μmol/L as normal). Blood cultures were performed
and the result was negative.
The admission diagnosis was upper respiratory tract
infection associated with low body weight. The infant
received intravenous injections of the antibiotic cefopera-
zone (0.1 g, twice daily) for 12 days. Meanwhile, his axil-
lary temperature was monitored every four hours.
Despite the treatment, he still showed an intermittent
fever (Figure 1). Blood routine tests were ordered on the
2nd, 4th, 8th, 12th, and 19th day since admission. On the
8th day of antibiotic treatment, his WBC count returned
to the normal range, but his Hb and PLT count continu-
ously decreased (Table 1). A malignant haematological
illness was suspected, and a bone marrow aspiration was
conducted. Surprisingly, examination of the bone mar-
row smear revealed P. vivax parasitized erythrocytes
(Figure 2A). This finding was later verified by nested
PCR using DNA isolated from the blood film (Figure 2B)
[16].
The infant was diagnosed as having congenital malaria
caused by P. vivax, a rare event in this area. Antibiotics
were immediately discontinued and anti-malarial treat-
ment was begun. He was given oral chloroquine phos-
phate (CQ) at 25 mg/kg for three days. Since parasites
were not completely cleared on day 3, additional three-
day treatment at 12 mg/kg was given. Since the initiation
of CQ treatment, he became afebrile (Figure 1). One
week later, his Hb level rose to 98 g/L (Table 1). He be-
came aparasitaemic seven days after CQ treatment was
started. He was discharged on the same day.
During the anti-malarial treatment of the infant, his
mother also received examinations for malaria infection.Figure 1 The infant’s body temperature. Shown here is an intermittent
anti-malarial(shown as an asterisk) and subsequent resolution of the fever.Two blood smears obtained at one week’s interval were
both microscopically negative. She was not given anti-
malarial treatment. In retrospect, the infant’s mother
recalled that she had an intermittent fever for about a
week in the 6th month of her pregnancy, but the symp-
toms were resolved without anti-malarial treatment.
Two follow-up visits at 6 and 12 months showed that
both the infant and mother did not develop further mal-
aria symptoms during this period.
Conclusions
In recent years, P. vivax has become the predominant
malaria parasite species in China [17]. Especially in the
temperate central provinces where malaria transmission
is unstable, P. vivax was the only species responsible for
malaria outbreaks occurred recently [18]. With consider-
able control efforts, the annual malaria incidence rate in
Anhui Province was significantly reduced in recent years
[17]. In city, P. vivax malaria is rare, especially during
the winter when malaria transmission is interrupted.
The P. vivax parasite in this region is typical of temper-
ate strains with a long relapse pattern. Occasionally,
patients develop malaria during the non-transmission
season, which often makes proper malaria diagnosis dif-
ficult. Febrile patients during winter time are normally
not considered for diagnosis of malaria infection. In the
present case, the patient was a newborn, and the onset
of malaria symptoms occurred when he was 20 days old.
Since the average temperature in February in Bengbu
city was 3.8°C, natural transmission of malaria could not
have occurred. In addition, his mother was a local resi-
dent without a travel history outside of Anhui province
during her pregnancy. During her pregnancy, she did
not receive anti-malarial treatment. Therefore, it wasfever pattern prior to the initiation of CQ treatment on the 12th day
Figure 2 Diagnosis of the congenital malaria. (A) Giemsa-stained film of the bone marrow aspiration from the infants showing P. vivax
infected erythrocytes (arrows, magnification 1,000×). (B) Confirmation of the diagnosis by nested PCR showing the ~125 bp PCR band specific for
P. vivax. M, DNA Ladder, Lane 1, P. vivax positive control; Lane 2, DNA extracted from the infant’s bone marrow film; Lane 3, Negative control.
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tion at the beginning. Only when haematological exam-
ination was performed on suspicion of haematological
illness, he was diagnosed of having vivax malaria infec-
tion. Since natural transmission was extremely unlikely,
the only possibility was transmission of the parasite from
the mother to the foetus during her pregnancy or at the
time of delivery.
Malaria infection during pregnancy can have a huge
impact on both the mother and the foetus. It can lead to
still birth, premature delivery, and low birth weight. Evi-
dently, congenital malaria is another serious challenge
for neonates’ healthcare [1,11]. For babies born to
mothers with active blood stage malaria infection or his-
tory of malaria infection during pregnancy, aggressive
monitoring of congenital malaria should be adopted.
Currently, there is little information about the preva-
lence of congenital P. vivax malaria [19], and equally un-
known is the impact of congenital malaria on neonates.
Therefore, this case of congenital vivax malaria during a
non-transmission season in a temperate region cautions
that neonates born in malaria-endemic regions with
fever should be examined for congenital malaria, espe-
cially when anemia or thrombocytopenia occurs.
Since primaquine is contraindicated in pregnancy,
there is no radical malaria treatment strategy for preg-
nant women with absolute safety to the foetus. Although
it has been shown that weekly CQ prophylaxis against
vivax malaria in pregnant women is safe and effective in
preventing vivax malaria [20], chemoprophylaxis for
pregnant women living under risk of P. vivax has not
been widely used [11]. In regions, such as the central
provinces of China, where clinical CQ resistance in P.
vivax malaria has not been documented and in vitro
assays showed that P. vivax was sensitive to CQ [21],CQ prophylaxis against vivax malaria during pregnancy
might be offered to high-risk populations. In addition,
considering the effects of congenital malaria on the
foetus and infant [1,13], antenatal care in malaria en-
demic areas to detect and treat malaria episodes during
pregnancy needs to be actively implemented.
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